In a deal worth nearly $1 billion, online pharma startup PharmEasy is buying out leading pathology laboratory chain Thyrocare Technologies to bolster its e-commerce play. Under the contours of the deal, API Holdings, the parent of PharmEasy is acquiring a 66% stake in Thyrocare from its main promoter A Velumani and his family for Rs 4,550 crore.from Business News: Latest News on Business, Stock Markets, Financial News, India Business & World Business News https://ift.tt/3h7QBnF
No comments:
Post a Comment